Concepedia

Evan Perry

EP

Statistics

Publications

5

Citations

230

H-Index

5

Active since

2014

Affiliations

Vanderbilt University(Current)

Evan Perry is an author at Vanderbilt University specializing in drug discovery, ligand-based design, and pharmacy.

Publications per year

2014–2019

5

Publications

5

Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer

Taekyu Lee, Plamen P. Christov, Subrata Shaw et al. · Journal of Medicinal Chemistry · 2019 · 67 citations · Full text

, , +13

Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design

Subrata Shaw, Zhiguo Bian, Bin Zhao et al. · Journal of Medicinal Chemistry · 2018 · 66 citations · Full text

, , +15

Fragment-based screening of programmed death ligand 1 (PD-L1)

Evan Perry, Jonathan J. Mills, Bin Zhao et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 55 citations · Full text

, , +14

Estimation of the Effects of Auxiliary Electrical Loads on Hybrid Electric Vehicle Fuel Economy

Kevin Rhodes, Daniël Kok, Pallav Sohoni et al. · SAE technical papers on CD-ROM/SAE technical paper series · 2017 · 24 citations

, , +14

Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris

Eliot T. Smith, Evan Perry, Megan Sears-Smith et al. · Protein Expression and Purification · 2014 · 18 citations · Full text

, , +16

1–5 of 5